Chemical activators of ZFP936 can initiate a cascade of intracellular signaling events leading to the protein's functional activation. Forskolin directly stimulates adenylate cyclase, an enzyme that catalyzes the conversion of ATP to cyclic AMP (cAMP). The rise in cAMP levels triggers the activation of protein kinase A (PKA), which phosphorylates target proteins, including ZFP936, thereby activating them. Similarly, IBMX acts as a non-selective inhibitor of phosphodiesterases, enzymes responsible for breaking down cAMP. By inhibiting these phosphodiesterases, IBMX indirectly contributes to the accumulation of cAMP and subsequent PKA activation, which can lead to the phosphorylation and activation of ZFP936. Dibutyryl-cAMP, a more stable cAMP analog, bypasses the need for adenylate cyclase activation and directly activates PKA, again leading to possible phosphorylation and activation of ZFP936.
Another pathway involves the activation of protein kinase C (PKC) by Phorbol 12-myristate 13-acetate (PMA), which then can phosphorylate ZFP936. The phosphorylation status of ZFP936 can also be influenced by the cellular phosphatase activity; inhibitors like Okadaic Acid and Calyculin A prevent dephosphorylation, thus maintaining ZFP936 in an active state. Calcium plays a critical role in the activation of certain kinases; chemicals such as A-23187 and Ionomycin act as calcium ionophores and increase intracellular calcium levels, which can activate calcium-dependent kinases that may target and activate ZFP936. Thapsigargin disrupts calcium homeostasis in a similar way, leading to kinase activation and potential activation of ZFP936. KN-93, by inhibiting calmodulin-dependent kinase II, can lead to the activation of alternative signaling pathways that may converge on ZFP936 activation. Lastly, stress-activated protein kinases, which can be activated by Anisomycin, and PKC, potentially activated by Chelerythrine, can modify ZFP936 through phosphorylation, thereby promoting its activation. Each chemical, through its distinct mechanism, ensures the activation of ZFP936 through direct or indirect phosphorylation events.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Activates adenylate cyclase, increasing cAMP levels which in turn activate PKA. PKA can phosphorylate and activate ZFP936. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
Inhibits phosphodiesterases, leading to increased cAMP and activation of PKA, which may result in the phosphorylation of ZFP936. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
A cAMP analog that directly activates PKA, which can phosphorylate and lead to the activation of ZFP936. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activates PKC, which can then phosphorylate serine and threonine residues on ZFP936 leading to its activation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
Inhibits protein phosphatases 1 and 2A, maintaining proteins like ZFP936 in a phosphorylated and active state. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A sc-24000B sc-24000C | 10 µg 100 µg 500 µg 1 mg | $160.00 $750.00 $1400.00 $3000.00 | 59 | |
Inhibits protein phosphatases, leading to an increase in phosphorylated proteins, which could include the activation of ZFP936. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
A calcium ionophore which increases intracellular calcium, potentially activating calcium-dependent kinases that activate ZFP936. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Increases intracellular calcium concentration, which may activate calcium-dependent kinases that could phosphorylate ZFP936. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Disrupts calcium homeostasis, possibly leading to activation of calcium-dependent kinases and subsequent activation of ZFP936. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $178.00 | 25 | |
Inhibits calmodulin-dependent kinase II, which can result in the activation of downstream proteins like ZFP936. |